Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal antimalarial products versus artemether + lumefantrine for uncomplicated malaria in Ghana
PACTR202109664146698Phase 3Completed
- Sponsor
- Bernard K.Turkson
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of artemether + lumefantrine in malaria (3 arms), sponsored by Bernard K.Turkson. Primary endpoints: Complete treatment of parasitemia and Toxicity testing. Started Aug 2019; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202109664146698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202109664146698.